The Latest Breaking News from FDA

Imagine the reaction if a federal court a few years back had ruled against a controversial White House executive order, and Trump administration officials responded by ignoring the decision. Apoplectic progressives would have taken to the streets to protest the president as an “existential threat to democracy” — and rightfully…

A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise.

Mifepristone will lose its FDA approval this week unless an appeals court intervenes in a case likely to reach the supreme court

WASHINGTON — Experts worry two recent rulings challenging the Food and Drug Administration’s regulation of a drug used in medication abortions threaten to complicate the agency’s oversight and the pipeline for future research and drug approvals.

"Durbin refuses to revoke the blue-slip tradition that willingly grants GOP the ability to obstruct," critic says

A bit of legal "whiplash" could occur in the next few days, one expert says

Critics of a court decision banning an abortion drug say the ruling undermines the FDA's ability to regulate the drug industry.

Big changes could be coming for how Americans pay for COVID-19 tests

The Biden administration on Monday asked a federal appeals court to allow women to continue to be able to access to the most commonly used abortion drug in the U.S. while a lawsuit over it plays out

ATLANTA — The Food and Drug Administration has taken up the regulation of tobacco products as a key issue to focus on in 2023, particularly prohibiting the sale of menthol cigarettes and flavored cigars and cigarillos.

DALLAS — Nine months after shuttering its Texas clinics, one of the nation’s largest independent abortion providers has opened a clinic in neighboring New Mexico.